Will Amgen's rare disease drug remain on the market in Japan by July 15, 2026?

This market resolves to Yes if Amgen’s rare disease drug is not withdrawn from the Japanese market by July 15, 2026, either due to regulatory action or the company's decision in response to the recent safety concerns.